| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Abstract
Summary
This report is an essential source for in-depth information and data relating
to the Canada Diabetes Care Devices devices market. It also offers detailed
and comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the Diabetes Care Devices in
Canada.
Scope
• The report provides diabetes care devices information broken down into
detailed categories and segments in Canada.
• Total revenues, products
sold, end users, and average pricing.
• Market shares of all the key
competitors.
• Key pipeline products that are set to shape the market,
broken down by sector.
• Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
• Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
• Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
•
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
• Customer, hospitals and physicians data.
Reasons to buy
• Gain a strong understanding of the diabetes care devices market in
Canada.
• Evaluate and compare the attractiveness of the market in the
country.
• Identify growth segments and opportunities in each industry
sector within the country.
• Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
• Analyze the competitiveness of the
market in the country and identify hotspots.
• Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
• Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
• Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
TABLE OF CONTENTS
Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2
Introduction 11
2.1 What Is This Report About? 11
2.2 Definitions
11
3 Healthcare Sector Review 13
3.1 Healthcare Expenditure 13
3.2
Healthcare Infrastructure 16
3.3 Healthcare Policy 18
4 Diabetes Care
Devices in Canada 20
4.1 Diabetes Care Devices Overall Revenues
(2000-2012) 20
4.2 Diabetes Care Devices Overall Volume (2000-2012) 26
4.3 Diabetes Care Devices Overall Company Share (2006-2007) 29
5 Glucose
Monitoring in Canada 30
5.1 Glucose Monitoring Overall Revenues
(2000-2012) 30
5.2 Glucose Monitoring Overall Volume (2000-2012) 38
5.3 Glucose Monitoring Average Price (2000-2012) 44
5.4 Glucose Monitoring
Distribution Share (2006-2007) 48
5.5 Glucose Monitoring Company Share
(2006-2007) 49
6 Insulin Delivery in Canada 50
6.1 Insulin Delivery
Overall Revenues (2000-2012) 50
6.2 Insulin Delivery Overall Volume
(2000-2012) 62
6.3 Insulin Delivery Average Price (2000-2012) 71
6.4
Insulin Delivery Distribution Share (2006-2007) 79
6.5 Insulin Delivery
Company Share (2006-2007) 80
7 F. Hoffmann-La Roche Ltd. Company Profile
81
7.1 Company Overview 81
7.2 Business Overview 81
7.3 Value
Chain Analysis 85
7.4 SWOT Analysis 87
7.5 Financial and Operational
Review 91
7.6 Locations And Subsidiaries 93
7.7 Financial Deals
Landscape 95
7.8 Recent Developments 150
8 LifeScan, Inc. Company
Profile 164
8.1 Company Overview 164
8.2 Business Overview 164
8.3
Locations And Subsidiaries 165
8.4 Recent Developments 167
8.5
LifeScan, Inc. Pipeline Products 167
9 Abbott Laboratories Company Profile
170
9.1 Company Overview 170
9.2 Business Overview 170
9.3 Value
Chain Analysis 175
9.4 SWOT Analysis 178
9.5 Financial and Operational
Review 182
9.6 Locations And Subsidiaries 184
9.7 Financial Deals
Landscape 185
9.8 Recent Developments 212
9.9 Abbott Laboratories
Pipeline Products 224
10 Novo Nordisk A/S Company Profile 232
10.1
Company Overview 232
10.2 Business Overview 232
10.3 Locations and
Subsidiaries 234
10.4 Recent Developments 236
10.5 Novo Nordisk A/S
Pipeline Products 243
11 Becton, Dickinson Company Profile 245
11.1
Company Overview 245
11.2 Business Overview 245
11.3 Value Chain
Analysis 249
11.4 SWOT Analysis 251
11.5 Financial and Operational
Review 255
11.6 Locations And Subsidiaries 257
11.7 Financial Deals
Landscape 259
11.8 Recent Developments 276
12 Regulation System
286
12.1 Medical Equipment Approval Process 286
12.2 Labeling and
Packaging 289
12.3 Post-Market Surveillance 289
13 Pricing and
Reimbursement 291
14 Distribution Structure 292
14.1 Distribution
Structure 292
15 Appendix 293
15.1 Global markets Direct Research
Methodology 293
15.2 Coverage 294
15.3 Secondary Research 294
15.4
Primary Research 295
15.5 Models 295
15.6 Forecasts 296
15.7
Expert Panels 296
15.8 Currency Conversion 297
15.9 Contact Us 298
15.10 Disclaimer 298
1.1 List of Tables
Table 1: Number
of Physicians by Province in Canada, 2001 and 2005 22
Table 2: Hospital
Wards by Specialty in Canada, 2003-2007 23
Table 3: Doctors by Specialty
in Canada, 2003-2007 24
Table 4: Diabetes Care Devices, Canada, Overall
Revenues ($ mn), 2000-2012 26
Table 5: Diabetes Care Devices, Canada,
Overall Revenues ($ mn), Historic, 2000-2007 27
Table 6: Diabetes Care
Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012 28
Table 7:
Diabetes Care Devices, Canada, Overall Revenues ($ mn), 2000-2012 29
Table
8: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
30
Table 9: Diabetes Care Devices, Canada, Overall Revenues ($ mn),
Forecast, 2007-2012 31
Table 10: Diabetes Care Devices, Canada, Overall
Volume (Units), 2000-2012 32
Table 11: Diabetes Care Devices, Canada,
Overall Volume (Units), Historic, 2000-2007 33
Table 12: Diabetes Care
Devices, Canada, Overall Volume (Units), Forecast, 2007-2012 34
Table 13:
Diabetes Care Devices, Canada, Overall Company Share by Revenue ($ mn),
2006-2007 35
Table 14: Glucose Monitoring, Canada, Overall Revenues ($
mn), Historic, 2000-2007 36
Table 15: Glucose Monitoring, Canada, Overall
Revenues ($ mn), Forecast, 2007-2012 37
Table 16: Glucose Monitoring,
Canada, Revenue by Segment ($ mn), Historic, 2000-2007 38
Table 17:
Glucose Monitoring, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012
39
Table 18: Blood Glucose Test Strips, Canada, Revenues ($ mn), Historic,
2000-2007 40
Table 19: Blood Glucose Test Strips, Canada, Revenues ($ mn),
Forecast, 2007-2012 41
Table 20: Blood Glucose Meters, Canada, Revenues ($
mn), Historic, 2000-2007 42
Table 21: Blood Glucose Meters, Canada,
Revenues ($ mn), Forecast, 2007-2012 43
Table 22: Glucose Monitoring,
Canada, Overall Volume (Units), Historic, 2000-2007 44
Table 23: Glucose
Monitoring, Canada, Overall Volume (Units), Forecast, 2007-2012 45
Table
24: Blood Glucose Test Strips, Canada, Volume (Units), Historic, 2000-2007
46
Table 25: Blood Glucose Test Strips, Canada, Volume (Units), Forecast,
2007-2012 47
Table 26: Blood Glucose Meters, Canada, Volume (Units),
Historic, 2000-2007 48
Table 27: Blood Glucose Meters, Canada, Volume
(Units), Forecast, 2007-2012 49
Table 28: Blood Glucose Meters, Canada,
Average Price ($), Historic, 2000-2007 50
Table 29: Blood Glucose Meters,
Canada, Average Price ($), Forecast, 2007-2012 51
Table 30: Blood Glucose
Test Strips, Canada, Average Price ($), Historic, 2000-2007 52
Table 31:
Blood Glucose Test Strips, Canada, Average Price ($), Forecast, 2007-2012
53
Table 32: Glucose Monitoring, Canada, Distribution Share by Revenue ($
mn), 2006-2007 54
Table 33: Glucose Monitoring, Canada, Company Share by
Revenue ($ mn), 2006-2007 55
Table 34: Insulin Delivery, Canada, Overall
Revenues ($ mn), Historic, 2000-2007 56
Table 35: Insulin Delivery,
Canada, Overall Revenues ($ mn), Forecast, 2007-2012 57
Table 36: Insulin
Delivery, Canada, Revenue by Segment ($ mn), Historic, 2000-2007 58
Table
37: Insulin Delivery, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012
59
Table 38: Insulin Syringes, Canada, Revenues ($ mn), Historic,
2000-2007 60
Table 39: Insulin Syringes, Canada, Revenues ($ mn),
Forecast, 2007-2012 61
Table 40: Insulin Pumps, Canada, Revenues ($ mn),
Historic, 2000-2007 62
Table 41: Insulin Pumps, Canada, Revenues ($ mn),
Forecast, 2007-2012 63
Table 42: Insulin Pens, Canada, Revenues ($ mn),
Historic, 2000-2007 64
Table 43: Insulin Pens, Canada, Revenues ($ mn),
Forecast, 2007-2012 65
Table 44: Insulin Jet Injectors, Canada, Revenues
($ mn), Historic, 2000-2007 66
Table 45: Insulin Jet Injectors, Canada,
Revenues ($ mn), Forecast, 2007-2012 67
Table 46: Insulin Delivery,
Canada, Overall Volume (Units), Historic, 2000-2007 68
Table 47: Insulin
Delivery, Canada, Overall Volume (Units), Forecast, 2007-2012 68
Table 48:
Insulin Syringes, Canada, Volume (Units), Historic, 2000-2007 69
Table 49:
Insulin Syringes, Canada, Volume (Units), Forecast, 2007-2012 70
Table 50:
Insulin Pens, Canada, Volume (Units), Historic, 2000-2007 71
Table 51:
Insulin Pens, Canada, Volume (Units), Forecast, 2007-2012 72
Table 52:
Insulin Pumps, Canada, Volume (Units), Historic, 2000-2007 73
Table 53:
Insulin Pumps, Canada, Volume (Units), Forecast, 2007-2012 74
Table 54:
Insulin Jet Injectors, Canada, Volume (Units), Historic, 2000-2007 75
Table 55: Insulin Jet Injectors, Canada, Volume (Units), Forecast, 2007-2012
76
Table 56: Insulin Jet Injectors, Canada, Average Price ($), Historic,
2000-2007 77
Table 57: Insulin Jet Injectors, Canada, Average Price ($),
Forecast, 2007-2012 78
Table 58: Insulin Pens, Canada, Average Price ($),
Historic, 2000-2007 79
Table 59: Insulin Pens, Canada, Average Price ($),
Forecast, 2007-2012 80
Table 60: Insulin Pumps, Canada, Average Price ($),
Historic, 2000-2007 81
Table 61: Insulin Pumps, Canada, Average Price ($),
Forecast, 2007-2012 82
Table 62: Insulin Syringes, Canada, Average Price
($), Historic, 2000-2007 83
Table 63: Insulin Syringes, Canada, Average
Price ($), Forecast, 2007-2012 84
Table 64: Insulin Delivery, Canada,
Distribution Share by Revenue ($ mn), 2006-2007 85
Table 65: Insulin
Delivery, Canada, Company Share by Revenue ($ mn), 2006-2007 86
Table 66:
F. Hoffmann-La Roche Ltd., SWOT Analysis, 2006 94
Table 67: F.
Hoffmann-La Roche Ltd., Financial Statements, CHF Million, 2002-2006 97
Table 68: F. Hoffmann-La Roche Ltd., Financial Ratios, CHF Million,
2002-2006 98
Table 69: F. Hoffmann-La Roche Ltd., Other Locations
99
Table 70: F. Hoffmann-La Roche Ltd., Other Locations(Contd..)
100
Table 71: F. Hoffmann-La Roche Ltd., Subsidiaries 100
Table
72: LifeScan, Inc., Other Locations 172
Table 73: Abbott
Laboratories, SWOT Analysis, 2006 184
Table 74: Abbott Laboratories,
Financial Statements, USD Thousand, 2002-2006 188
Table 75: Abbott
Laboratories, Financial Ratios, USD Thousand, 2002-2006 189
Table 76:
Abbott Laboratories, Other Locations 190
Table 77: Abbott
Laboratories, Subsidiaries 191
Table 78: Novo Nordisk A/S, Other
Locations 240
Table 79: Novo Nordisk A/S, Subsidiaries 241
Table
80: Becton, Dickinson and Company, SWOT Analysis, 2006 257
Table 81:
Becton, Dickinson and Company, Financial Statements, USD Thousand,
2002-2006 261
Table 82: Becton, Dickinson and Company, Financial
Ratios, USD Thousand, 2002-2006 262
Table 83: Becton, Dickinson and
Company, Share Holding Structure 263
Table 84: Becton, Dickinson and
Company, Other Locations 264
Table 85: Medical Equipment Classification in
Canada, 2007 292
Table 86: Medical Equipment Licensing Fee in Canada, 2007
294
Table 87: Medical Equipment License Processing Duration in Canada,
2007 295
Table 88: Currency Conversion from USD to Local Currency at
2007 Constant Rate 303
1.2 List of Figures
Figure 1:
Healthcare Financing in Canada, 2004 20
Figure 2: Healthcare Expenditure
in Canada, 2000 - 2006 21
Figure 3: Diabetes Care Devices, Canada, Overall
Revenues ($ mn), 2000-2012 26
Figure 4: Diabetes Care Devices, Canada,
Overall Revenues ($ mn), Historic, 2000-2007 27
Figure 5: Diabetes Care
Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012 28
Figure 6:
Diabetes Care Devices, Canada, Overall Revenues ($ mn), 2000-2012 29
Figure 7: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Historic,
2000-2007 30
Figure 8: Diabetes Care Devices, Canada, Overall Revenues ($
mn), Forecast, 2007-2012 31
Figure 9: Diabetes Care Devices, Canada,
Overall Volume (Units), 2000-2012 32
Figure 10: Diabetes Care Devices,
Canada, Overall Volume (Units), Historic, 2000-2007 33
Figure 11: Diabetes
Care Devices, Canada, Overall Volume (Units), Forecast, 2007-2012 34
Figure 12: Diabetes Care Devices, Canada, Overall Company Share (%), 2007
35
Figure 13: Glucose Monitoring, Canada, Overall Revenues ($ mn),
Historic, 2000-2007 36
Figure 14: Glucose Monitoring, Canada, Overall
Revenues ($ mn), Forecast, 2007-2012 37
Figure 15: Glucose Monitoring,
Canada, Revenue by Segment ($ mn), Historic, 2000-2007 38
Figure 16:
Glucose Monitoring, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012
39
Figure 17: Blood Glucose Test Strips, Canada, Revenues ($ mn),
Historic, 2000-2007 40
Figure 18: Blood Glucose Test Strips, Canada,
Revenues ($ mn), Forecast, 2007-2012 41
Figure 19: Blood Glucose Meters,
Canada, Revenues ($ mn), Historic, 2000-2007 42
Figure 20: Blood Glucose
Meters, Canada, Revenues ($ mn), Forecast, 2007-2012 43
Figure 21: Glucose
Monitoring, Canada, Overall Volume (Units), Historic, 2000-2007 44
Figure
22: Glucose Monitoring, Canada, Overall Volume (Units), Forecast, 2007-2012
45
Figure 23: Blood Glucose Test Strips, Canada, Volume (Units), Historic,
2000-2007 46
Figure 24: Blood Glucose Test Strips, Canada, Volume (Units),
Forecast, 2007-2012 47
Figure 25: Blood Glucose Meters, Canada, Volume
(Units), Historic, 2000-2007 48
Figure 26: Blood Glucose Meters, Canada,
Volume (Units), Forecast, 2007-2012 49
Figure 27: Blood Glucose Meters,
Canada, Average Price ($), Historic, 2000-2007 50
Figure 28: Blood Glucose
Meters, Canada, Average Price ($), Forecast, 2007-2012 51
Figure 29: Blood
Glucose Test Strips, Canada, Average Price ($), Historic, 2000-2007 52
Figure 30: Blood Glucose Test Strips, Canada, Average Price ($), Forecast,
2007-2012 53
Figure 31: Glucose Monitoring, Canada, Distribution Share
(%), 2007 54
Figure 32: Glucose Monitoring, Canada, Company Share (%),
2007 55
Figure 33: Insulin Delivery, Canada, Overall Revenues ($ mn),
Historic, 2000-2007 56
Figure 34: Insulin Delivery, Canada, Overall
Revenues ($ mn), Forecast, 2007-2012 57
Figure 35: Insulin Delivery,
Canada, Revenue by Segment ($ mn), Historic, 2000-2007 58
Figure 36:
Insulin Delivery, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012
59
Figure 37: Insulin Syringes, Canada, Revenues ($ mn), Historic,
2000-2007 60
Figure 38: Insulin Syringes, Canada, Revenues ($ mn),
Forecast, 2007-2012 61
Figure 39: Insulin Pumps, Canada, Revenues ($ mn),
Historic, 2000-2007 62
Figure 40: Insulin Pumps, Canada, Revenues ($ mn),
Forecast, 2007-2012 63
Figure 41: Insulin Pens, Canada, Revenues ($ mn),
Historic, 2000-2007 64
Figure 42: Insulin Pens, Canada, Revenues ($ mn),
Forecast, 2007-2012 65
Figure 43: Insulin Jet Injectors, Canada, Revenues
($ mn), Historic, 2000-2007 66
Figure 44: Insulin Jet Injectors, Canada,
Revenues ($ mn), Forecast, 2007-2012 67
Figure 45: Insulin Syringes,
Canada, Volume (Units), Historic, 2000-2007 69
Figure 46: Insulin
Syringes, Canada, Volume (Units), Forecast, 2007-2012 70
Figure 47:
Insulin Pens, Canada, Volume (Units), Historic, 2000-2007 71
Figure 48:
Insulin Pens, Canada, Volume (Units), Forecast, 2007-2012 72
Figure 49:
Insulin Pumps, Canada, Volume (Units), Historic, 2000-2007 73
Figure 50:
Insulin Pumps, Canada, Volume (Units), Forecast, 2007-2012 74
Figure 51:
Insulin Jet Injectors, Canada, Volume (Units), Historic, 2000-2007 75
Figure 52: Insulin Jet Injectors, Canada, Volume (Units), Forecast, 2007-2012
76
Figure 53: Insulin Jet Injectors, Canada, Average Price ($), Historic,
2000-2007 77
Figure 54: Insulin Jet Injectors, Canada, Average Price ($),
Forecast, 2007-2012 78
Figure 55: Insulin Pens, Canada, Average Price ($),
Historic, 2000-2007 79
Figure 56: Insulin Pens, Canada, Average Price ($),
Forecast, 2007-2012 80
Figure 57: Insulin Pumps, Canada, Average Price
($), Historic, 2000-2007 81
Figure 58: Insulin Pumps, Canada, Average
Price ($), Forecast, 2007-2012 82
Figure 59: Insulin Syringes, Canada,
Average Price ($), Historic, 2000-2007 83
Figure 60: Insulin Syringes,
Canada, Average Price ($), Forecast, 2007-2012 84
Figure 61: Insulin
Delivery, Canada, Distribution Share (%), 2007 85
Figure 62: Insulin
Delivery, Canada, Company Share (%), 2007 86
Figure 63: F.
Hoffmann-La Roche Ltd., Value Chain Analysis 91
Figure 64: Abbott
Laboratories, Value Chain Analysis 181
Figure 65: Becton, Dickinson
and Company, Value Chain Analysis 255
Figure 66: Global markets Direct
Methodology 299
|
